COVID-19 in a multiple sclerosis (MS) patient treated with alemtuzumab: Insight to the immune response after COVID
Celsi Fiorella, Galleguillos Lorna
Topics & Concepts
AlemtuzumabMultiple sclerosisCoronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Immune systemBetacoronavirusPandemicVirologyImmunologyInternal medicineAntibodyDiseaseInfectious disease (medical specialty)OutbreakLong-Term Effects of COVID-19Multiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 Research